Medical | Page 320 of 472 | SpiritIndia.com

Urinary Tract Infection :: Treatments for urinary infections leave bacteria bald, happy and vulnerable

A different approach to treating urinary tract infections (UTIs) could defeat the bacteria that cause the infections without directly killing them, a strategy that could help slow the growth of antibiotic-resistant infections. Researchers at Washington University School of Medicine in St. Louis have been working to create pharmaceuticals that essentially “defang” the bacteria by preventing them from assembling pili, microscopic hairs that enable the bacteria to invade host cells.

Pain :: FDA amends labeling changes to OTC Pain Relievers

The Food and Drug Administration (FDA) today proposed to amend the labeling regulations on over-the-counter (OTC) Internal Analgesic, Antipyretic, and Antirheumatic (IAAA) drug products to include important safety information regarding the potential for stomach bleeding and liver damage and when to consult a doctor. OTC IAAA drug products, commonly known as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen, naproxen and ketoprofen, are used to treat pain, fever, headaches, and muscle aches.

Healthcare :: McKesson announces live RFID application for real-time tracking

McKesson, the world’s largest healthcare services, automation and information technology company, today announced the implementation of Horizon Real-Time Location System? , the company?s new radio frequency identification (RFID) solution, at Spartanburg Regional Medical Center, Spartanburg, S.C. Following a comprehensive evaluation period, Spartanburg is using the RFID solution to wirelessly track and electronically record the location history of 550 intravenous (IV) infusion pumps throughout its facility.

Imaging :: New MRI technique measures intracranial pressure in brain disorder

A new advanced magnetic resonance imaging technique developed at the University of Illinois at Chicago for the diagnosis of neurological problems, such as Chiari malformations, hydrocephalus and brain injury, will be evaluated for clinical use through a $1.4 million National Institutes of Health Bioengineering Research Partnership grant.

Dementia :: Non-drug treatments for dementia show promise

Memory training and other non-drug treatments may one day help older adults ward off declines in mental function, according to researchers from Wake Forest University School of Medicine in an editorial in the current issue of the Journal of the American Medical Association.

Leukemia :: Predicting risk of leukemia induced by radiation therapy

A new analysis shows that it may be possible to accurately predict a cancer patient?s risk of developing leukemia as a result of receiving radiation therapy for a primary tumor. Understanding these risks may help doctors optimize radiation treatment to minimize the side effects of this therapy, the authors say.

Lung Cancer :: Palliative radiotherapy better in late-stage lung cancer

A longer, less intense course of radiotherapy provides better value for the money than a shorter, more intense regimen when given to ease pain and other complaints in patients with late-stage non-small-cell lung cancer (NSCLC), according to a study in the December 20 issue of the Journal of the National Cancer Institute.

Vitamin D :: Vitamin D lowers multiple sclerosis risk

New research suggests that having higher circulating levels of vitamin D is associated with a reduced risk for multiple sclerosis, although this relationship was not seen for black and Hispanic individuals, according to a study in the Dec. 20 issue of JAMA.

Kidney Stones :: Kidney stones and nanoparticles

Researchers at Mayo Clinic have successfully isolated nanoparticles from human kidney stones in cell cultures and have isolated proteins, RNA and DNA that appear to be associated with nanoparticles.

Heart Disease :: Blood transfusions raise heart patients’ infection risk

Blood transfusions save the lives of millions of heart surgery patients and others each year. But a new study suggests that patients who receive transfusions during heart bypass surgery have a higher risk of developing potentially dangerous infections, and dying, after their operation.